An appropriate and controlled supply of thyroid hormones is vital for proper body function. In turn, an appropriate synthesis of T3 and T4 in the thyroid gland is dependent on a sufficient and balanced iodide concentration in blood serum. Due to widespread iodine deficiency or some cases of iodine over exposure, iodide biomonitoring in serum is important and it is that biomonitoring approach being closest to the bioavailable I(-) supply for the thyroid gland. Therefore, this paper describes a biomonitoring method for iodide determination in serum based on ion chromatography-inductively coupled plasma mass spectrometry (IC-ICP-MS). Since in literature only very few data are available on iodide in serum but many in urine the method is also extended to I(-) monitoring in urine. The method was additionally designed to have short analysis time (8min) for increased sample throughput, good precision in serial measurement (serum: 4.86%; urine: 1.4%), and day-to-day determination (serum: 5.7%; urine: 2.28%), high accuracy (serum: 105%; urine: 101%) and good recovery (serum: 102%; urine: 99%) even in matrix-rich samples at low I(-) concentration. Also, investigations were performed to elucidate whether internal standardization during chromatography, sample preparation for protein-matrix removal or matrix-matched calibration are advantageous for analytical performance. Finally, limits of detection (3σ) of 0.12μg/L or 0.05μg/L (serum or urine) and limit of quantification (10σ) of 0.39μg/L or 0.17μg/L (serum or urine) were achieved.
Keywords: IC–ICP-MS; Iodide; Serum; Urine.
Copyright © 2014 Elsevier GmbH. All rights reserved.